SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).
Clinical trial NCT00442572 · COMPLETED
Trial details
- NCT number
- NCT00442572
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-03
- Primary completion
- 2012-04-23
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.